Overview Of Value Stocks In The Healthcare Sector
Portfolio Pulse from Benzinga Insights
Benzinga Insights has identified notable value stocks in the healthcare sector based on low P/E multiples. First Wave BioPharma (FWBI), Kiora Pharmaceuticals (KPRX), TherapeuticsMD (TXMD), Voyager Therapeutics (VYGR), and Organon (OGN) are highlighted as undervalued. FWBI, KPRX, and VYGR reported decreased earnings per share in their latest quarters, while TXMD saw an increase, and OGN experienced a decrease but also reported a higher dividend yield.
November 27, 2023 | 2:43 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
First Wave BioPharma's Q2 EPS decreased by 3.85%, indicating potential concerns for growth prospects.
A decrease in EPS typically signals potential issues to investors, which could lead to a negative short-term impact on the stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Kiora Pharmaceuticals' Q3 EPS decreased by 12.66%, which may raise concerns among investors.
A significant decrease in EPS could be viewed negatively by the market, potentially leading to a decrease in stock price in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Voyager Therapeutics' EPS saw a decrease from Q2, which might concern investors about the company's profitability.
A decrease in EPS can be a negative signal to the market, potentially leading to a short-term decline in the stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEUTRAL IMPACT
Organon's EPS decreased this quarter, but the dividend yield increased, which might attract income-focused investors.
While a decrease in EPS is typically negative, the increase in dividend yield could offset this impact by attracting dividend-seeking investors, leading to a neutral short-term impact.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
TherapeuticsMD's EPS improved from Q2 to the current quarter, which could be seen positively by investors.
An improvement in EPS is generally a positive indicator for investors and could lead to an increase in the stock price in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80